These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 7808958)

  • 1. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
    Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
    Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
    Wu SF; Chen AC; Peng CT; Wu KH
    Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
    Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE
    Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
    Chiewchengchol D; Wananukul S; Noppakun N
    Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.
    Morimoto A; Imamura T; Ishii R; Nakabayashi Y; Nakatani T; Sakagami J; Yamagami T
    Cancer; 2008 Sep; 113(6):1362-9. PubMed ID: 18661511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
    Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
    Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia.
    Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):57-60. PubMed ID: 8039761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
    Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
    Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus and pancreatitis as a complication of L-asparaginase therapy.
    Charan VD; Desai N; Singh AP; Choudhry VP
    Indian Pediatr; 1993 Jun; 30(6):809-10. PubMed ID: 8132268
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
    Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N
    Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503
    [No Abstract]   [Full Text] [Related]  

  • 12. Does octreotide prevent L-asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia?
    Tokimasa S; Yamato K
    Br J Haematol; 2012 May; 157(3):381-2. PubMed ID: 22145577
    [No Abstract]   [Full Text] [Related]  

  • 13. L-asparaginase-induced pancreatitis in children with acute lymphoblastic leukemia: is allopurinol protective?
    Muwakkit S; Saab R; Yazbeck N; Samia L; Abboud MR
    Pediatr Hematol Oncol; 2010 Sep; 27(6):496-501. PubMed ID: 20578808
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.
    Earl M
    Clin Adv Hematol Oncol; 2009 Sep; 7(9):600-6. PubMed ID: 20020672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
    Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
    Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute pancreatitis secondary to L-asparaginase (a case report)].
    Tazi I; Rachid M; Quessar A; Harif M; Benchekroun S
    East Mediterr Health J; 2009; 15(2):475-9. PubMed ID: 19554997
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical manifestation of toxic pancreas lesion in children with hematopoietic malignancies].
    Balcerska A; Maciejka-Kapuścińska L; Kosiak W
    Wiad Lek; 1998; 51 Suppl 4():90-6. PubMed ID: 10731949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.
    Plourde PV; Jeha S; Hijiya N; Keller FG; Silverman LB; Rheingold SR; Dreyer ZE; Dahl GV; Mercedes T; Lai C; Corn T
    Pediatr Blood Cancer; 2014 Jul; 61(7):1232-8. PubMed ID: 24436152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
    Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
    Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.